$LUCD 8-K SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Unregistered Sales of Equity Securities; Material Modifications to Rights of Security Holders +1 more He is the Chief Executive Officer of Lucid Diagnostics Inc., a Delaware corporation (the “Corporation”).
16 Oct 2026	8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
22 Sep 2026	8-K: Regulation FD Disclosure Medicare Advisory Panel recommends maintaining EsoGuard’s original gapfill payment basis under the Clinical Laboratory Fee Schedule
13 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
24 Jun 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
14 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
24 Apr 2026	8-K: Regulation FD Disclosure; Other Events
23 Apr 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
26 Mar 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
12 Nov 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
25 Sep 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
11 Sep 2025	8-K: Regulation FD Disclosure; Other Events
10 Sep 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
13 Aug 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
18 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
30 May 2025	8-K: Entry into a Material Definitive Agreement
14 May 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
25 Apr 2025	8-K: Changes in Registrant's Certifying Accountant
11 Apr 2025	8-K: Regulation FD Disclosure; Other Events
10 Apr 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure

Comments